Medicine and Dentistry
Immune Checkpoint Inhibitor
57%
Squamous Cell Carcinoma
43%
Immunotherapy
38%
Skin Cancer
38%
Nevus
33%
Lung
33%
Pembrolizumab
30%
Melanoma
30%
Tipiracil
28%
Purpura
28%
Stasis Dermatitis
28%
Betamethasone Valerate
28%
Sun Exposure
28%
Lid Margin Neovascularized Area
28%
Trifluridine
28%
Liquid Nitrogen
28%
Notch
28%
Cosmetics
28%
Adverse Event
28%
Vulva Carcinoma
28%
Melanocytic Nevus
28%
Metastatic Melanoma
28%
CTLA-4
28%
Immune Checkpoint Blockade
28%
Hand Sanitizer
28%
Phytophotodermatitis
28%
Cryotherapy
28%
Chronic Myelomonocytic Leukemia
28%
Immune System
28%
Erythema
28%
Vulva
28%
Dermatomyositis
28%
Histiocytosis
28%
Necrobiotic Xanthogranuloma
28%
Dermatological Agent
28%
Hypersensitivity Angiitis
28%
Superficial Basal Cell Carcinoma
28%
Lichenoid
28%
Rhinophyma
28%
Nail
28%
Granuloma Annulare
28%
Malignant Neoplasm
24%
Carcinoma
23%
Side Effect
23%
Henoch-Schönlein Purpura
22%
HMB-45
19%
Maturation
19%
Primary Health Care
19%
Skin Metastasis
19%
Skin Biopsy
19%
Keyphrases
Cutaneous Adverse Drug Reactions (cADRs)
91%
Linear IgA Bullous Dermatosis
57%
Metastatic Melanoma
40%
Pembrolizumab
31%
Trifluridine-tipiracil
28%
Acne Severity
28%
Examination Stress
28%
Betamethasone Valerate
28%
Stasis Dermatitis
28%
Leukocytoclastic Vasculitis
28%
Combination Immunotherapy
28%
Incidence Management
28%
Clinical Benefit
28%
Inhibitor Therapy
28%
Generalized Eruptive Histiocytosis
28%
Purpura
28%
Notch Inhibitor
28%
Vancomycin
28%
Phytophotodermatitis
28%
Dermatomyositis
28%
Management Benefits
28%
Longitudinal Erythronychia
28%
Anti-PD-1
28%
Necrobiotic Xanthogranuloma
28%
Acitretin
28%
Anti-CTLA-4
28%
Vemurafenib
28%
Liquid Nitrogen Cryotherapy
28%
Lung Squamous Cell Carcinoma
28%
Acne Rosacea
28%
Rosaceae
28%
Psoriasiform Eruption
28%
Late-onset
28%
Immune Checkpoint Inhibitors
28%
Henoch-Schönlein Purpura
22%
Specific Quality of Life
17%
Adverse Effects
17%
Neoplasms
17%
Squamous Cell Carcinoma (SqCC)
17%
Skin Cancer
15%
Informational Economy
14%
Economic Intervention
14%
Inhibitor Treatment
14%
Notch Signaling
14%
Medication Side Effects
12%
Checkpoint Inhibitors
11%
Dermatology Life Quality Index
11%
Older Men
11%
Keratoacanthoma
11%
Healthy Cells
9%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Vancomycin
57%
Bullous Skin Disease
57%
Immunoglobulin A
57%
Neoplasm
38%
Alopecia
28%
Sorafenib
28%
Thyroid Carcinoma
28%
Betamethasone Valerate
28%
Chemotherapy
28%
Stevens Johnson Syndrome
28%
Vemurafenib
28%
Etretin
28%
Bupropion
28%
Granuloma Annulare
28%
Psoriasis
17%
Squamous Cell Carcinoma
17%
Diseases
15%
Sun Protective Clothing
14%
Keratoacanthoma
11%
Phenmetrazine
11%
Polypharmacy
11%
Metastatic Melanoma
11%
Hand Foot Syndrome
11%
Drug Induced Disease
11%
Dermatological Agent
9%
Atopic Dermatitis
9%
Carcinoma
9%
Suppurative Hidradenitis
9%
Skin Disease
9%
Lichen Planus
9%
Retinoid
5%
Papule
5%
Clinical Research
5%
Renal Cell Carcinoma
5%
Skin Cancer
5%
Actinic Keratosis
5%
Skin Carcinoma
5%
Carcinogenesis
5%
Postinflammatory Hyperpigmentation
5%
Isotretinoin
5%
Hair Loss
5%
B Raf Kinase Inhibitor
5%
Chemoprophylaxis
5%
Solid Malignant Neoplasm
5%
Liver Cell Carcinoma
5%
Non Melanoma Skin Cancer
5%